Results 291 to 300 of about 110,913 (348)

Adipose-Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Shimada T   +18 more
europepmc   +1 more source

Impact of the Timing of Initial Anamorelin Administration in Advanced Gastrointestinal Cancer With Cancer Cachexia. [PDF]

open access: yesIn Vivo
Yoshida D   +9 more
europepmc   +1 more source

Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database. [PDF]

open access: yesTher Adv Med Oncol
Morimoto K   +12 more
europepmc   +1 more source

Temporal Trends in Mortality Related to Pancreatic Cancer and Cachexia in the United States. [PDF]

open access: yesCureus
Pakkirisamy Kannan S   +5 more
europepmc   +1 more source

Ponsegromab: The new miracle drug for cancer cachexia.

open access: yesIndian J Pharmacol
Paikray E, Rout A, Tripathy R.
europepmc   +1 more source

Cancer-associated cachexia

Nature Reviews Disease Primers, 2018
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation.
Vickie E Baracos   +2 more
exaly   +6 more sources

Definition and classification of cancer cachexia: an international consensus

Lancet Oncology, The, 2011
Ingvar Bosaeus   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy